1. Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
   Kwangho Kim et al, 2023, Experimental & Molecular Medicine CrossRef
2. The SMYD family proteins in immunology: An update of their obvious and non-obvious relations with the immune system
   Teresa Rubio-Tomás, 2021, Heliyon CrossRef
3. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer
   Eid Alshammari et al, 2022, World Journal of Gastroenterology CrossRef
4. Functions of SMYD proteins in biological processes: What do we know? An updated review
   Ascensión Rueda-Robles et al, 2021, Archives of Biochemistry and Biophysics CrossRef
5. SMYD2 aggravates gastrointestinal stromal tumor via upregulation of EZH2 and downregulation of TET1
   Yong Ji et al, 2022, Cell Death Discovery CrossRef
6. Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification
   Futaba Inoue et al, 2024, International Journal of Oncology CrossRef
7. Dissecting the Role of SMYD2 and Its Inhibitor (LLY-507) in the Treatment of Chemically Induced Non-Small Cell Lung Cancer (NSCLC) by Using Fe3O4 Nanoparticles Drug Delivery System
   Aasma Munawwar et al, 2023, Pharmaceuticals CrossRef
8. Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine
   Ryuji Hamamoto et al, 2020, Cancers CrossRef
9. Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications
   Teresa Rubio-Tomás, 2021, Molecular Biology Reports CrossRef
10. Recent advances in epigenetic anticancer therapeutics and future perspectives
    Liwen Ren et al, 2023, Frontiers in Genetics CrossRef
11. LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer
    Meng Yue et al, 2021, Cancer Cell International CrossRef
12. Clinical prognostic value of the SMYD2/3 as new epigenetic biomarkers in solid cancer patients: a systematic review and meta-analysis
    Mahdieh Razmi et al, 2022, Expert Review of Molecular Diagnostics CrossRef
13. Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
    An Tong et al, 2023, Frontiers in Genetics CrossRef
14. Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space
    Lama Prema Dhorma et al, 2022, European Journal of Medicinal Chemistry CrossRef
15. SMYD Protein Family as Promising Biomarkers for Cancer Diagnosis and Prognosis
    Yingxue Zhang et al, 2022, Genomic and Epigenomic Biomarkers of Toxicology and Disease CrossRef